Clinical Trial Update: Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating mycophenolate mofetil in combination with standard of care for glioblastoma; study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioblastoma
• Glioblastoma Idh-wildtype
• Mgmt-unmethylated Glioblastoma

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Northwestern University | Conditions: Astrocytoma, Glioblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING